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ime for a new approach to case reportsCase reports are popular and represent one of the oldest lev-
ls of evidence. Despite this they have attracted much criticism.
hey can be trivial, their conclusions do not usually undergo fur-
her investigation, and they are often questioned as a poor excuse
or an unstructured review of the literature. Lessons from the past
avegivenstrongwarningsagainstusingnewdrugsbased solelyon
ase reports, such as the long-term adverse consequences of fetal
xposure to diethylstilboestrol (DES) in pregnancy.1 Case reports
re often not cited and hence many journals routinely reject them
o protect their impact factors. Indeed, there is evidence that the
revalence of these articles in high impact journals is in decline.2
Many journals have reconsidered their policy towards case
eports over the years3,4 and there has been a recent vogue in
ew journals publishing exclusively case reports,5–7 one of which
s no longer active.8 The International Journal of Surgery (IJS) has
ad dissonance towards case reports since its launch in 2003.
umbers steadily rose until they formed over a quarter of submis-
ions in 2007. Under the weight of these submissions we chose
o institute a policy of non-acceptance in late 2007, our instruc-
ions to authorswere updated andmany enthusiastic authorswere
ejected. Despite this, case reports have continued to be submit-
ed in large numbers. We tentatively started to accept case reports
gain inmid-2009with the bar set very high onquality andnovelty.
e feel the timehasnowcome for theﬁrst dedicatedhome for such
rticles – International Journal of Surgery: Case Reports (IJSCR). The
ournal is due for launch on 20 May 2010 and the IJS itself will no
onger accept case reports from this point forward. This editorial
rovides a synoptic exposition for this major change in direction
nd its underlying rationale.
Clinicians– and surgeons inparticular – learn fromstories, anec-
otes and patient-based learning. Such learning has been essential
o the advance of healthcare.9 Clinical knowledge is remembered
ar more efﬁciently when tagged to real-life events; this is per-
aps to be expected amongst human beings working in such a
ighly organised social environment. Case reports can be very sen-
itive at detecting novelty. By deﬁnition, the discovery of every new
ondition, be it AIDS, SARS, Swine Flu or the next emergent dis-
ase begins with a single case. They complement evidence-based
edicine, the learning of which should be drawn from a broad
ange of sources.10,11 A recent study of drugs withdrawn from the
arket found the scientiﬁc evidence for 19 out of 21 drugs came
romspontaneous case reports. Case reportswere the sole evidence
n 12 and a randomised controlled trial (RCT) was only responsible
or one.12–15 Aronson16 and Glasziou et al.17 have described cir-
umstances where case reports have provided deﬁnitive not just
ndicative evidence. Individual cases can also have a major impact
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Open access under CC BYon health policy. In the UK, on 4 February 2010, Coroner William
Morris ruled the death of a 70-year-old patient who was admin-
istered a tenfold overdose of diamorphine by a German GP was
an unlawful killing.18 This resulted in prompt action by the UK
Government to prevent similar cases.19
The relatively ‘open’ format of case reports for discussing atypi-
cal presentations, diagnostic challenges/pitfalls and rare conditions
is especially useful. Their less rigid structure allows the surgeon(s)
to discuss their diagnostic approach, the context, background,
decision-making, reasoning and outcomes. Their human perspec-
tive would be of unique and special value and provide insights
into the doctor–patient relationship. In addition, by writing about
their experiences, surgeons gain the opportunity to reﬂect on their
practice, an important aspect of personal development often not
afforded the time amongst busy clinics and theatre lists. Yet we
know their intrinsic value from patient safety incidents, root cause
analysis, morbidity and mortality meetings.
Case reports may remain the ‘lowest’ or ‘weakest’ level of evi-
dence with respect to causality but they remain the ﬁrst line of
evidence ofwhat actually happened. They allow for the demonstra-
tion of novel surgical techniques (as laparoscopic cholecystectomy
was once upon a time) prior to more substantial comparative anal-
ysis with established techniques such as RCTs. The need for more
case reports may have been paradoxically increased by the drive
for big RCTs. One of us (RA) has already demonstrated some of the
problems with surgical RCTs.20 People with three or more chronic
conditions account for around 80% of healthcare activity; however,
the evidence base that relates to such people is poor. RCTs tend
to exclude patients who have more one than chronic condition
in order to limit the number of variables, potential confounding
factors and to aid interpretation. Yet how many of us deal with
patients who may have two or more of the following: diabetes,
arthritis, heart failure, depression, chronic obstructive airways dis-
ease, asthma and so on. This is not uncommon, 40% of patients
with long-termconditionshavemore thanonecondition, andmany
have three or more.21 UK National Institute for Health and Clinical
Excellence (NICE) guidelines are based on trials that deliberately
excluded patients with comorbidities. You just cannot do RCTs
on every kind of patient but these are the types of patients we
see day in day out. The importance of not forgetting outliers has
been discussed elsewhere.22 Outliers in larger studies are statisti-
cally sidelined and further analysis of unexplained and unexpected
observations is not conducted. It is therefore hard for such patients
and their surgeon to know what’s best.
The other issue is generalisability. RCTs are often conducted
in centres of excellence with the necessary funding, support and
-NC-ND license.
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tructure to make them happen. Their results may not be easily
xtrapolated to low- and middle-income countries with limited
esources. RCT evidence on children, tropical diseases and surgi-
al conditions not found in the developed world is particularly
oor.23 Searching our database for patients in similar circum-
tances treated to the best possible standards locally in the health
ervice structure and cost-base of that countrywould provide value
nd aid the decision-making process for both surgeon and patient.
uch reports stimulate learning and research and are capable of
eveloping new subject areas as well as providing excellent educa-
ional material to students, trainees and lecturers. The addition of
ultimedia facilities such as online video is of particular relevance
o surgery – a craft specialty.
In recent times, the ﬁrst face transplant24 and the ﬁrst uterine
ransplant25 were presented as single cases. Despite the technical
uccesses and failures of such attempts at novel transplantations,
he reports themselves allowed the international scientiﬁc and sur-
ical community to gain useful insights at the ‘cutting edge’. We
earnt about the technical difﬁculties, immunological issues, psy-
hosocial and ethical dilemmas from the ‘front line’ so to speak. It
s with the richness of such cases and demand from authors that
e feel the time has come to launch IJSCR.
IJSCR will be online-only, peer reviewed and will only publish
ase reports which are clinically interesting, original and edu-
ational. All published content will be universally available to
veryone on our dedicated website www.casereports.com and the
cience Direct platform (www.sciencedirect.com), which is one of
he world’s most advanced web delivery systems for scientiﬁc,
edical and technical content hosting more than 10 million arti-
les with more than 11 million users. All published content will
e publicly posted on PubMedCentral (PMC) and our aim is to ulti-
ately achieve indexing inMedline aswell. The journalwill also be
ndexed in SCOPUS, EMBASE and Google Scholar soon after launch
n 20 May. This business model of freely accessible content will
ecessitate all authors paying an article processing fee of £250
plusVAT/Sales tax) should their article be accepted for publication.
his is in keeping with other journals that operate such a business
odel26 and compares favourably.
Types of cases we will be interested in include:
1. Reminder of an important clinical lesson.
2. ‘How I do it’.
3. Findings that shed new light on the possible pathogenesis of a
disease or an adverse effect.
4. Learning from errors.
5. Unusual presentation of more common disease/injury.
6. Myth exploded.
7. Rare disease.
8. New disease.
9. Novel diagnostic procedure.
0. Novel treatment (new drug/intervention, established
drug/procedure in new situation, use of new technology).
1. Unusual association of diseases/symptoms.
2. Unexpected outcome (positive or negative) including adverse
drug reactions.
Cases will be judged on clinical interest and educational
alue not novelty or rarity. All authors should refer to
ur Guide to Authors available online in the ﬁrst instance
http://ees.elsevier.com/ijscasereports). We expect case reports to
e short and simple toprepare, thusproviding an idealway trainees
o gain writing and publishing experience.
This new journal in no way detracts from more rigorous studies
hich the IJS will continue to publish and we wish to echo Sir Iain
halmers’ comments27 in response to the launch of another casegery Case Reports 1 (2010) 1–3
reports journal:
“In 1952, Austin Bradford Hill – the medical statistician who
play such an important part in introducing the randomized
controlled trial to medical research – ‘In my indictment of the
statistician, I would argue that he may tend to be a triﬂe too
scornful of the clinical judgments, the clinical impression. Such
judgments are, I believe, in essence, statistical;. The clinician
is attempting to make a comparison between the situation that
faces himat themoment and amentally recorded but otherwise
untabulated past experience’. Twenty years later, Sam Shuster –
aclinician–warned that these impressions canbe seriouslymis-
leading: ‘There are lies, damned lies, and clinical impressions’28.
Both Bradford Hill and Shuster are right, of course: informal
evaluation of care based on impressions, and formal evaluation
based on well-controlled comparisons of alternative forms of
care, both play essential roles in the promotion ofmore effective
care. . .”
We aim to develop the science of case reports and raise their
academic value. Ultimately, these case reports will form a rich
database, a corpus of clinical information which could be mined
for interesting trends/patterns, disease modelling and for the pur-
poses of surveillance (especially of rare diseases). Examples of such
collective value internationally include:
• The Global Trigger Tool from the Institute for Healthcare
Improvement (IHI) in the USA which has been shown to increase
the rate of adverse drug event detection approximately 50-fold
over traditional reporting methodologies.29
• The Medicines and Healthcare products Regulatory Agency’s
(MHRA) YellowCard30 reporting system for adverse drug reac-
tions (ADRs).
• The National Patient Safety Agency (NPSA) in the UK, whose
National Learning and Reporting System31 (NLRS) relies on single
cases and where extraction of systemic lessons from such data is
now beginning to bear fruit.32
• The BEACH (Bettering the Evaluation And Care of Health) pro-
gramme in Australia has used 100 consecutive and randomly
sampled case reports each year from general practitioners to
describe ‘the characteristics of GPs and the patients who consult
them, patient reasons for encounter, the problems managed and
management techniques used’. The programme now has over 10
years of data and has been very important in developing general
practice in Australia.33
We hope that our database will be greater than the sum of
its parts too and the ‘wisdom of crowds’ will take it to new
heights.34 This editorial represents an open call to the Sherlock
Holmes within us all and to the wider surgical community. Join
us in this exciting new venture and demonstrate the rich diver-
sity of clinical surgery by submitting your best cases to IJSCR at:
http://ees.elsevier.com/ijscasereports.
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